@ShahidNShah
COVID-19 and Real World Evidence
Even with all the data gathered during this pandemic, there is still so much that we don’t know about the virus and won’t know for years to come. In response, the health care industry needs to gather as much data about patients and vaccine recipients as possible to guide treatment decisions, identify risks, and inform standards of care.
In the near term, this data will help us to better understand the acute impact of the disease and the effectiveness of new vaccines. In the long term, real-world data from COVID-19 patients will show us how the virus impairs the body, what new health risks it creates, and what long-term complications will emerge.
Continue reading at ajmc.com
Make faster decisions with community advice
- Digital Mental Health on the Rise, but Engagement, Access and Trust Continue to Be Barriers
- How Organizations Can Integrate Precision Medicine With Clinical Care
- Improving Digital Patient Engagement During COVID-19: Geisinger’s Evolution
- Interoperability Breakthroughs to Advance Value-Based Care and Improve Clinical and Financial Outcomes
- Rising Risks to Patient Data and HIPAA Compliance in the Age of COVID-19
Next Article
-
The Healthcare Holy Grail: A Health Plan’s Guide to Succeeding With Their Value-Based Care Strategy
As health plans move towards quality over quantity-based reimbursement models, they are under immense pressure to ingest and operationalize new datasets to properly inform and pay the providers that …